XEPLION

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug XEPLION contains one active pharmaceutical ingredient (API):

1	Paliperidone UNII R8P8USM8FR - PALIPERIDONE PALMITATE
	Paliperidone is a selective blocking agent of monoamine effects, whose pharmacological properties are different from that of traditional neuroleptics. Even though paliperidone is a strong D2-antagonist, which is believed to relieve the positive symptoms of schizophrenia, it causes less catalepsy and decreases motor functions to a lesser extent than traditional neuroleptics.
	Read more about Paliperidone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
XEPLION Prolonged release suspension for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AX13	Paliperidone	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1519534, 1519545, 1519556, 1519567, 1519578, 1519589
ES	Centro de información online de medicamentos de la AEMPS	11672002, 11672003, 11672004, 11672005
FI	Lääkealan turvallisuus- ja kehittämiskeskus	058609, 409745, 412581, 536460
FR	Base de données publique des médicaments	60713079, 64760254, 65554816, 66614262, 68716209
GB	Medicines & Healthcare Products Regulatory Agency	192091, 192101, 192107, 192110
IE	Health Products Regulatory Authority	34251, 34252, 34253, 34254
IL	מִשְׂרַד הַבְּרִיאוּת	6715, 6716, 6717, 6718
IT	Agenzia del Farmaco	041004019, 041004021, 041004033, 041004045, 041004058, 041004060
JP	医薬品医療機器総合機構	1179409G1025, 1179409G2021, 1179409G3028, 1179409G4024, 1179409G5020, 1179409G6027, 1179409G7023, 1179409G8020, 1179409G9026
LT	Valstybinė vaistų kontrolės tarnyba	1059526, 1059552, 1059553, 1059554, 1059555, 1059556
NL	Z-Index G-Standaard	15641937
NL	Z-Index G-Standaard, PRK	100218, 96954, 96962, 96970, 96989, 96997
PL	Rejestru Produktów Leczniczych	100245661, 100245678, 100245684, 100245690, 100245709, 100245715
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W57256001, W57257001, W57258001, W57259001, W57260001
TR	İlaç ve Tıbbi Cihaz Kurumu	8699593950049, 8699593950056, 8699593950063, 8699593950070